Prefilled Unit-Dose Avastin® (Bevacizumab) Syringes


avastin eye 701

Edge Pharma offers FDA compliant prefilled ready-to-administer compounded Avastin® (Bevacizumab) syringes for eye injections.


Avastin® Ophthalmic Injection 

Concentration = 3.25 mg / 0.13 mL
Avastin® Syringe Volume = 0.13 mL in a silicone-free Norm-Ject syringe


Avastin® Syringe Features 

  • Silicone-Free Norm-Ject syringes
  • Meet new FDA requirements for subvisible particle testing
  • Order in packs of 20 or 80 syringes
  • Every batch of compounded Avastin® syringes from Edge Pharma undergoes rigorous sterility, potency, endotoxin, visual inspection, and subvisible particle analysis before release.



According to the American Academy of Ophthalmology "Avastin® is a drug used to treat wet age-related macular degeneration (AMD). It is also used to treat diabetic eye disease and other problems of the retina. It is injected into the eye to help slow vision loss from these diseases.

Avastin® is the brand name for the drug, which is called bevacizumab. It blocks the growth of abnormal blood vessels in the back of the eye. Those blood vessels can leak and affect vision, causing vision loss from wet AMD and diabetic eye disease.

Avastin® is one of several anti-VEGF treatments that are injected into the eye.

Avastin® was first approved by the Food and Drug Administration (FDA) to treat different types of cancer. Its use to treat eye disease is considered an “off-label” use. The FDA allows “off label” drug use if doctors are well informed about the product and studies prove the drug is helpful."



 National Institutes of Health, April 30, 2012

Avastin and Lucentis are equivalent in treating age-related macular degeneration.


Register To Order Online 

Please fill the Form below to create an account. Medical, DEA, or hospital pharmacy licenses are required to order prefilled Avastin® syringes.

Create an account to order

Log-In if you have an account